Penserra Capital Management’s GeneDx Holdings WGS Stock Holding History

Penserra Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,608	Closed	-$927K	–	1142
2025 Q3	$927K	Sell	8,608 -17,548	-67%	-$1.91M	0.01%	459
2025 Q2	$2.41M	Buy	26,156 +5,915	+29%	+$464K	0.03%	317
2025 Q1	$1.79M	Buy	20,241 +10,501	+108%	+$911K	0.03%	321
2024 Q4	$748K	Buy	+9,740	New	+$680K	0.01%	486
2022 Q3	–	Sell	-239	Closed	-$9K	–	1228
2022 Q2	$9K	Buy	239 +45	+23%	+$3.05K	﹤0.01%	1287
2022 Q1	$19K	Sell	194 -31	-14%	-$3.45K	﹤0.01%	1278
2021 Q4	$33K	Sell	225 -530	-70%	-$118K	﹤0.01%	1130
2021 Q3	$189K	Buy	755 +392	+108%	+$135K	﹤0.01%	632
2021 Q2	$167K	Sell	363 -168	-32%	-$72.1K	﹤0.01%	678
2021 Q1	$260K	Buy	+531	New	+$276K	﹤0.01%	548

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Penserra Capital Management's WGS Position: Q4 2025 in Review

Penserra Capital Management sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 8,608 shares — an estimated $927K sold.

Penserra Capital Management first reported a position in WGS in Q1 2021 and held it in 10 quarters. The position peaked at $2.41M in Q2 2025. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

Penserra Capital Management reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
Penserra Capital Management sold 8,608 GeneDx Holdings shares in Q4 2025, an estimated $927K.
Penserra Capital Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 10 quarters.
Penserra Capital Management's GeneDx Holdings position peaked at $2.41M in Q2 2025.
286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.